LEGALDIGMLEGALDIGM
    ← Code of Federal Regulations
    Beta
    21 CFR § 520.1445

    21 CFR § 520.1445 — § 520.1445 Milbemycin oxime and praziquantel.

    Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.

    Analyze this law with AI
    § 520.1445 Milbemycin oxime and praziquantel. (a) Specifications. Each chewable tablet contains: (1) 2.3 milligrams (mg) milbemycin oxime and 22.8 mg praziquantel; (2) 5.75 mg milbemycin oxime and 57 mg praziquantel; (3) 11.5 mg milbemycin oxime and 114 mg praziquantel; or (4) 23 mg milbemycin oxime and 228 mg praziquantel. (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter. (c) Conditions of use —(1) Dogs —(i) Amount. Administer orally, once a month, a minimum dosage of 0.23 mg per pound (mg/lb) of body weight (0.5 mg per kilogram (mg/kg)) milbemycin oxime and 2.28 mg/lb of body weight (5 mg/kg) praziquantel. (ii) Indications for use. For the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of adult roundworm ( Toxocara canis, Toxascaris leonina ), adult hookworm ( Ancylostoma caninum ), adult whipworm ( Trichuris vulpis ), and adult tapeworm ( Taenia pisiformis, Echinococcus multilocularis, E. granulosus, and Dipylidium caninum ) infections in dogs and puppies 2 pounds of body weight or greater and 6 weeks of age and older. (iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (2) [Reserved] [77 FR 47512, Aug. 9, 2012, as amended at 82 FR 58556, Dec. 13, 2017]

    Related guides, FAQ and contract templates